| X4 Pharma Heads to Nasdaq Via Reverse Merger with Arsanis | Ben Fidler | 11/27/18 | Boston |
| East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More | Ben Fidler | 09/04/15 | Boston |
| Ragan Reunites Ex-Genzymers at X4 Pharma to Battle Cancer | Ben Fidler | 09/01/15 | Boston |
| Stealthy X4 Pharma, Aided by Termeer, Other Ex-Genzymers, Nabs $37M+ | Ben Fidler | 09/01/15 | Boston |
| Ascent Therapeutics’ Blood Cancer Drug Could Rival Genzyme’s Mozobil | Ryan McBride | 09/16/09 | Boston |
| Genzyme Wins FDA Approval of Mozobil | Luke Timmerman | 12/15/08 | Boston |
| Genzyme Expects FDA Review of Myozyme Factory by Thanksgiving Weekend | Luke Timmerman | 09/23/08 | Boston |
